Sarah Earley

Title: Sarah Earley: Innovator in Breast Cancer Assessment

Introduction

Sarah Earley is a notable inventor based in Dublin, Ireland. She has made significant contributions to the field of medical diagnostics, particularly in breast cancer assessment. Her innovative methods aim to improve the prognosis and diagnosis of breast cancer recurrence.

Latest Patents

Sarah Earley holds a patent for a method of assessing cancer status in breast cancer patients. This patent describes methods for evaluating recurrence status by assaying a biological sample for specific biomarkers, such as S100β or HOX-C1I. Positive detection of these biomarkers indicates a higher likelihood of recurrence, which can be crucial for determining the prognosis of disease-free survival. The method is particularly useful for patients undergoing first-line therapy or those who have had surgery to remove a primary breast tumor.

Career Highlights

Throughout her career, Sarah has worked with prestigious institutions, including University College Dublin and the Royal College of Surgeons in Ireland. Her work has been instrumental in advancing the understanding of breast cancer and improving patient outcomes.

Collaborations

Sarah has collaborated with notable colleagues, including Leonie Young and Marie McIlroy. These partnerships have contributed to her research and the development of her innovative methods.

Conclusion

Sarah Earley's contributions to breast cancer diagnostics exemplify the impact of innovation in healthcare. Her work not only enhances the understanding of cancer recurrence but also offers hope for improved patient management and outcomes.